Ethical implications of artificial intelligence in skin cancer diagnostics: use-case analyses
Findings from our ethical use-case analysis of two patient-facing AI-assisted skin cancer apps suggest inadequate incorporation of bioethical norms such as justice, responsibility and transparency into the development and deployment of both apps. Improved regulation should increase accountability. Ensuring ethics by design through integration between technology developers, dermatologists, ethicists and the public is urgently needed to prevent the potential benefits of AI-assisted skin cancer apps being overshadowed by potential ethical harms.
Authors
- Eli Harriss (ORCID: https://orcid.org/0000-0003-4635-8959)
- Simona Tiribelli (ORCID: https://orcid.org/0000-0003-4101-5914)
- Rubeta Matin (ORCID: https://orcid.org/0000-0002-9695-5412)
- Syed Fazal Hussein Shah (ORCID: https://orcid.org/0000-0003-0624-1246)
- Heather Draper (ORCID: https://orcid.org/0000-0002-0020-4252)
- Daniel Arecco
Institutions
- John Radcliffe Hospital (GB)
- University of Warwick (GB)
- University of Oxford (GB)
- Oxford University Hospitals NHS Trust (GB)
- Harvard Global Health Institute (US)
- Tech Foundation (US)
- Bodle Technologies (United Kingdom) (GB)
- University of Macerata (IT)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1093/bjd/ljae434
- Citations
- 8
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.26